Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 14, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	38	32	21	54	120	34
Market Cap Growth	39.61%	56.90%	-62.03%	-55.00%	250.73%	-57.04%
Enterprise Value	26	7	-10	8	92	16
Last Close Price	2.60	3.42	2.76	7.32	28.80	18.22
Debt / Equity Ratio	-	-	0.01	0.00	0.00	0.01
Asset Turnover	-	-	-	-	0.01	-
Quick Ratio	5.76	14.09	8.41	13.56	38.80	2.00
Current Ratio	6.06	14.26	8.59	13.89	39.50	2.50
Return on Equity (ROE)	-22.89%	-19.82%	-48.15%	-11.98%	-57.33%	-212.26%
Return on Assets (ROA)	-15.16%	-9.25%	-10.96%	-7.94%	-15.70%	-51.13%
Return on Capital (ROIC)	-17.83%	-10.83%	-12.86%	-9.23%	-19.45%	-119.57%
Buyback Yield / Dilution	-34.86%	-28.16%	-21.09%	-148.46%	-40.25%	-55.79%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q